Muslim
Editorial Note: This resource was originally published on February 24, 2025, and has been updated through June 2026 to reflect the ongoing cascade of executive actions, agency directives, and judicial interventions shaping the landscape of LGBTQ+ health care in the United States.
Introduction: A Fundamental Shift in Federal Health Policy
Since the first day of his second term, President Donald Trump has initiated a sweeping transformation of federal health policy, specifically targeting the programs, data collection efforts, and nondiscrimination protections that support LGBTQ+ individuals. By redefining biological sex, restricting federal funding for gender-affirming care, and dismantling diversity, equity, and inclusion (DEI) frameworks, the administration has fundamentally altered the federal government’s relationship with the LGBTQ+ community.
These actions, characterized by the administration as a return to "biological truth," have created a profound environment of uncertainty for patients, providers, and public health agencies. This guide details the executive and administrative actions that have redefined the landscape of health care access for transgender and gender-diverse Americans over the past 18 months.
Chronology of Administrative Actions
The administration’s approach has been characterized by a multi-pronged strategy: rescinding existing protections, conditioning federal grants on adherence to new "sex-based" definitions, and utilizing the Department of Justice (DOJ) and Federal Trade Commission (FTC) to conduct investigations into medical providers.
Early Rescissions and the Redefinition of Sex (Q1 2025)
The administration began by rescinding key Biden-era executive orders, including Executive Orders 13988 and 14075, which had established the White House Gender Policy Council and prioritized LGBTQ+ equity. Following these rescissions, the administration issued a broad directive defining sex as an "immutable binary biological classification," explicitly rejecting the recognition of gender identity in federal agency operations.
The Crackdown on Gender-Affirming Care (2025–2026)
Central to the administration’s health agenda has been the effort to curb gender-affirming care (GAC), particularly for minors. Key directives include:
- January 2025: The Executive Order "Protecting Children from Chemical and Surgical Mutilation" was issued, directing agencies to rescind policies based on the World Professional Association for Transgender Health (WPATH) standards.
- March 2025: The Department of Veterans Affairs (VA) announced it would phase out gender-affirming medical services, barring exceptions for veterans already mid-treatment.
- May 2026: The administration ramped up legal pressure, with the DOJ issuing grand jury subpoenas to major health systems—including NYU Langone, Stanford Children’s, and Mount Sinai—demanding exhaustive patient records and communications related to gender-affirming treatments.
- June 2026: A new rule finalized by the Centers for Medicare & Medicaid Services (CMS) prohibited federal Medicaid and CHIP funds from covering gender-affirming hormonal or surgical care for youth, with limited exceptions.
Supporting Data and the "Wolves in White Coats" Report
The administration has utilized commissioned reports to justify its policy shift. In early 2026, the Department of Health and Human Services (HHS) released a report titled Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine’.
This report identified over 100 providers who the administration claims engaged in "anomalous billing patterns." HHS Secretary Kennedy subsequently referred these providers to the Office of Inspector General (OIG) for investigation. However, independent health policy experts at the Kaiser Family Foundation (KFF) and other institutions have noted that the report conflates medication costs with provider revenue and ignores the small, medically documented share of the population that utilizes these interventions.
Furthermore, the administration has utilized the Federal Trade Commission (FTC) to launch investigations into medical organizations like the American Academy of Pediatrics and the Endocrine Society, alleging "unfair practices" in the marketing of gender-affirming care.
Judicial Interventions and Legal Challenges
The executive actions have triggered an unprecedented wave of litigation. The judicial response has been bifurcated, with some courts blocking implementation of federal directives while others have allowed specific investigative tactics to proceed.
- Preliminary Injunctions: Federal courts in Maryland and Washington have issued temporary restraining orders blocking the administration from conditioning or withholding federal funding from hospitals that provide gender-affirming care.
- The Rhode Island/Texas Conflict: A notable legal battle emerged between the Northern District of Texas (which favored the administration’s subpoena power) and the District of Rhode Island (which quashed a subpoena directed at Rhode Island Hospital to protect patient privacy).
- Administrative Authority: In March 2026, a federal judge ruled from the bench that HHS overstepped its authority with its declaration that gender-affirming care failed to meet "professionally recognized standards," effectively vacating the declaration for the 21 plaintiff states involved in the suit.
- Patient Protections: In response to grand jury subpoenas, federal courts in the Southern District of New York and the Northern District of California have granted temporary restraining orders protecting patient health information, preventing institutions from handing over sensitive medical records to the DOJ.
Implications for Health Care Access and Public Health
The cumulative impact of these actions is a "chilling effect" that extends far beyond the specific services banned.
Disruption of Care
For transgender patients, the removal of the "exceptions process" for mid-treatment patients in Federal Employee Health Benefits (FEHB) and the prohibition of Medicaid coverage for youth creates a fragmented care environment. Many families are left with the choice of paying out-of-pocket for medically necessary care or experiencing a forced detransition due to lack of access to hormone therapy.
The Erosion of Data and Research
The removal of Sexual Orientation and Gender Identity (SOGI) questions from federal surveys, such as those in the Transformed Medicaid Statistical Information System (T-MSIS), hampers the ability of researchers to track health disparities. Without this data, public health officials cannot effectively allocate resources to address elevated rates of HIV or mental health crises within the LGBTQ+ community.
Institutional Risk and Provider Attrition
The use of criminal investigations and grand jury subpoenas against pediatric hospitals has caused many institutions to preemptively scale back or shutter their gender-affirming care programs. This creates a dangerous "care desert" for transgender youth, forcing families to travel across state lines to find providers—provided those providers have not already been intimidated into silence.
Impact on HIV and Mental Health
By redefining "gender ideology" and restricting the Ryan White HIV/AIDS Program from funding services that support transgender identities, the administration has jeopardized the "whole-person care" model that has been central to HIV suppression efforts. When providers are forced to choose between adhering to federal mandates that deny patient identity or losing their funding, they are often forced to disengage from the very communities most in need of clinical support.
Conclusion: A Future in Flux
The period of 2025–2026 has marked a fundamental departure from the scientific consensus held by major medical associations—including the American Psychological Association and the American Academy of Pediatrics—which maintain that gender-affirming care is medically necessary and evidence-based.
As litigation continues to wind through the circuit courts, the administration remains committed to its objective of removing gender-affirming services from the federal health care ecosystem. For the LGBTQ+ community, the coming years will be defined by a persistent tension between state-level protections, judicial oversight, and a federal executive branch that is actively working to dismantle the infrastructure of equitable health care access.
The administration’s strategy of leveraging financial, regulatory, and investigative pressure has created a new paradigm where access to health care is increasingly contingent upon adherence to a narrow, government-sanctioned definition of biological reality, leaving millions of Americans to navigate an increasingly hostile health care landscape.
Reynand Wu
Sagoh
